Literature DB >> 11442354

RNA editing at the Q/R site for the glutamate receptor subunits GLUR2, GLUR5, and GLUR6 in hippocampus and temporal cortex from epileptic patients.

G Kortenbruck1, E Berger, E J Speckmann, U Musshoff.   

Abstract

Posttranscriptional editing of mRNA is a phenomenon that generates molecular heterogeneity and functional variety. With the intention to test if RNA editing plays a role in pathological processes, which contribute to seizure maintenance, we examined the ratio of the unedited (Q) to edited (R) form of the AMPA receptor subunit GluR2 and kainate receptor subunits GluR5 and GluR6 in the hippocampus and temporal cerebral cortex, both excised from patients with pharmacoresistant temporal lobe epilepsies. We compared the data with samples from nonepileptic human control tissue (autopsy tissue). The ratio of Q/R editing was analyzed by means of reverse transcription-polymerase chain reaction followed by a restriction enzyme assay. We found that the editing efficiency for the kainate receptor subunits GluR5 and GluR6 was significantly higher in temporal cortex than in normal controls. The alteration in GluR5 and GluR6 mRNA editing in the neocortical tissue may reflect an adaptive reaction of ongoing seizure activity to prevent excessive Ca(2+) influx. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442354     DOI: 10.1006/nbdi.2001.0394

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

Review 1.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

Review 2.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

Review 3.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

4.  Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.

Authors:  Dama Laxminarayana; Kenneth S O'Rourke; Stefan Maas; Irene Olorenshaw
Journal:  Immunology       Date:  2007-03-22       Impact factor: 7.397

5.  PKC and polyamine modulation of GluR2-deficient AMPA receptors in immature neocortical pyramidal neurons of the rat.

Authors:  Jieun Shin; Fran Shen; John Huguenard
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

6.  Altered intrathalamic GABAA neurotransmission in a mouse model of a human genetic absence epilepsy syndrome.

Authors:  Chengwen Zhou; Li Ding; M Elizabeth Deel; Elizabeth A Ferrick; Ronald B Emeson; Martin J Gallagher
Journal:  Neurobiol Dis       Date:  2014-11-04       Impact factor: 5.996

7.  AMPA receptor properties are modulated in the early stages following pilocarpine-induced status epilepticus.

Authors:  Isabella Russo; Daniela Bonini; Luca La Via; Sergio Barlati; Alessandro Barbon
Journal:  Neuromolecular Med       Date:  2013-03-15       Impact factor: 3.843

8.  Induction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-epsilon and anti-CD28.

Authors:  Dama Laxminarayana; Islam U Khan; Kenneth S O'Rourke; Banabihari Giri
Journal:  Immunology       Date:  2007-09-25       Impact factor: 7.397

Review 9.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

10.  GluK2-mediated excitability within the superficial layers of the entorhinal cortex.

Authors:  Prateep S Beed; Benedikt Salmen; Dietmar Schmitz
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.